A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
This study primary objective and endpoints are compare the efficacy of two products
containing filgrastim, evaluating if the formulation produced by Eurofarma can be considered
non-inferior to the reference product.